Puretech Health co-founder and board member Dr Robert Langer wins global engineering prize
pharmafile | October 26, 2015 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing | Dr Robert Langer, Engineering, PureTech Health, Queen Elizabeth engineering prize
Dr Robert Langer, the co-founder of PureTech Health, has won the Queen Elizabeth prize for engineering.
The award is in recognition of his revolutionary advances and leadership in engineering at the interface with chemistry and medicine.
The global Queen Elizabeth Prize is the world’s biggest engineering accolade, and celebrates the engineers responsible for a ground-breaking innovation that has been of global benefit to humanity. In this case, the Queen Elizabeth Prize committee stated that “hundreds of millions of people a year across the world benefit from the technologies that rest on the work of Robert Langer.”
Dr Langer is also a board member of PureTech, and one of 13 institute professors at the Massachusetts Institute of Technology, the highest honour that can be awarded to a faculty member. His research laboratory is the largest academic biomedical engineering lab in the world, with over 100 researchers.
He has won an array of prizes and awards, including the Charles Stark Draper prize (2002), the 2008 Millennium prize, the 2013 Wolf prize, and the 2014 Kyoto prize. He is one of only four living individuals to have received both the United States National medal of science and the United States National medal of technology and innovation.
Daphne Zohar, chief executive of PureTech, comments: “On behalf of everyone at PureTech, I want to congratulate Bob on receiving the Queen Elizabeth prize for engineering in recognition of his work on controlled release large molecule drug delivery. His ground-breaking work has had a far-reaching impact, and we are delighted to have access to his knowledge and expertise as a co-founder and board member of PureTech.”
Related Content
PureTech Health launches Seaport Therapeutics
PureTech Health has announced key progress on its ‘strategic initiatives to deliver innovative medicines to …
PureTech Health’s Founded Entity Akili announces positive data from adult ADHD trial
Clinical-stage biotherapeutics company PureTech Health has reported that its Founded Entity Akili, a digital medicine …
Digital software shows benefit in ADHD trial
A pilot study of a digital health technology designed to improve symptoms of attention deficit …
